Manina Medtech develops Seedchrony, a first-in-class medical device designed to assess endometrial receptivity in real-time for embryo transfer procedures. By analyzing biomarker data within the uterus without invasive biopsies, the technology aims to increase IVF pregnancy rates by up to 30%. The solution combines hardware probes with AI-driven software to provide immediate, accurate insights to clinicians, enhancing individualized embryo transfer strategies. Supported by research institutions like Vall d'Hebron Hospital, Seedchrony addresses the critical unmet need for precision in evaluating endometrial development to improve synchronization between embryo and uterus.